1 asset in Primary Cutaneous T-Cell Lymphoma
Therapeutic assets addressing Primary Cutaneous T-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Fenretinide Primary Cutaneous T-Cell Lymphoma | SciTech Development, Inc. | P1 | CC (43) |